Status:
UNKNOWN
Russian Cardiovascular Registry of COVID-19
Lead Sponsor:
Federal State Budgetary Institution, V. A. Almazov Federal North-West Medical Research Centre, of the Ministry of Health
Conditions:
Covid19
Acute Cardiovascular Disease
Eligibility:
All Genders
18+ years
Brief Summary
This is a Russian multicenter observational study aimed to assess the mid-term and long-term prognosis in patients recovered from COVID-19 with the involvement of the cardiovascular system or with bas...
Detailed Description
This open multi-center observational study (registry) is designed to enroll consecutive eligible patients hospitalized with and recovered from COVID-19 (ICD-10 codes U07.1 or U07.2) with the involveme...
Eligibility Criteria
Inclusion
- Age ≥18 years of age
- Hospitalization with confirmed or suspected COVID-19 (ICD-10 codes U07.1 or U07.2)
- Involvement of the cardiovascular system or baseline severe cardiovascular diseases defined as at least of the following:
- proven or suspected myocarditis;
- heart failure (NYHA functional class II-IV) before or during hospitalization with COVID-19;
- combination of COVID-19 with ACS or development of ACS during hospitalization with COVID-19 or performed percutaneous coronary intervention;
- proven pulmonary embolism;
- hemodynamically significant arrhythmias (atrial fibrillation, high-grade ventricular premature beats, paroxysmal ventricular arrhythmias), including those associated with the QT interval prolongation
Exclusion
- None
Key Trial Info
Start Date :
September 11 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2022
Estimated Enrollment :
900 Patients enrolled
Trial Details
Trial ID
NCT04724707
Start Date
September 11 2020
End Date
December 1 2022
Last Update
January 26 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Almazov National Medical Research Centre
Saint Petersburg, Russia, 197341